Free Trial
NASDAQ:MASI

Masimo (MASI) Stock Price, News & Analysis

$124.74
-1.91 (-1.51%)
(As of 11:39 AM ET)
Today's Range
$124.31
$126.56
50-Day Range
$115.24
$146.85
52-Week Range
$75.22
$169.58
Volume
107,481 shs
Average Volume
609,137 shs
Market Capitalization
$6.62 billion
P/E Ratio
84.86
Dividend Yield
N/A
Price Target
$138.71

Masimo MarketRank™ Stock Analysis

Analyst Rating
Hold
2.43 Rating Score
Upside/​Downside
10.8% Upside
$138.71 Price Target
Short Interest
Bearish
7.97% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.86
Upright™ Environmental Score
News Sentiment
0.61mentions of Masimo in the last 14 days
Based on 13 Articles This Week
Insider Trading
Selling Shares
$5.45 M Sold Last Quarter
Proj. Earnings Growth
7.69%
From $3.64 to $3.92 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.70 out of 5 stars

Medical Sector

63rd out of 918 stocks

Electromedical Equipment Industry

2nd out of 19 stocks

MASI stock logo

About Masimo Stock (NASDAQ:MASI)

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.

MASI Stock Price History

MASI Stock News Headlines

Masimo: Promising Developments
See More Headlines
Receive MASI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Masimo and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/07/2024
Today
5/21/2024
Next Earnings (Estimated)
8/13/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Electromedical equipment
Sub-Industry
Health Care Equipment
Current Symbol
NASDAQ:MASI
CUSIP
57479510
Employees
5,200
Year Founded
1989

Price Target and Rating

Average Stock Price Target
$138.71
High Stock Price Target
$170.00
Low Stock Price Target
$86.00
Potential Upside/Downside
+9.5%
Consensus Rating
Hold
Rating Score (0-4)
2.43
Research Coverage
7 Analysts

Profitability

Net Income
$81.50 million
Pretax Margin
4.39%

Debt

Sales & Book Value

Annual Sales
$2.05 billion
Cash Flow
$5.88 per share
Book Value
$25.79 per share

Miscellaneous

Free Float
47,937,000
Market Cap
$6.72 billion
Optionable
Optionable
Beta
0.99

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

MASI Stock Analysis - Frequently Asked Questions

Should I buy or sell Masimo stock right now?

7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Masimo in the last twelve months. There are currently 4 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" MASI shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MASI, but not buy additional shares or sell existing shares.
View MASI analyst ratings
or view top-rated stocks.

What is Masimo's stock price target for 2024?

7 brokerages have issued 12 month price objectives for Masimo's shares. Their MASI share price targets range from $86.00 to $170.00. On average, they expect the company's share price to reach $138.71 in the next year. This suggests a possible upside of 10.8% from the stock's current price.
View analysts price targets for MASI
or view top-rated stocks among Wall Street analysts.

How have MASI shares performed in 2024?

Masimo's stock was trading at $117.21 at the start of the year. Since then, MASI stock has increased by 6.8% and is now trading at $125.21.
View the best growth stocks for 2024 here
.

When is Masimo's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 13th 2024.
View our MASI earnings forecast
.

How were Masimo's earnings last quarter?

Masimo Co. (NASDAQ:MASI) announced its earnings results on Tuesday, May, 7th. The medical equipment provider reported $0.77 EPS for the quarter, topping analysts' consensus estimates of $0.71 by $0.06. The medical equipment provider had revenue of $492.80 million for the quarter, compared to analysts' expectations of $487.70 million. Masimo had a trailing twelve-month return on equity of 13.26% and a net margin of 4.01%. The business's revenue for the quarter was down 12.8% compared to the same quarter last year. During the same quarter last year, the firm posted $0.87 earnings per share.

What guidance has Masimo issued on next quarter's earnings?

Masimo issued an update on its second quarter 2024 earnings guidance on Wednesday, May, 8th. The company provided earnings per share (EPS) guidance of 0.730-0.790 for the period, compared to the consensus estimate of 0.770. The company issued revenue guidance of $480.0 million-$510.0 million, compared to the consensus revenue estimate of $503.8 million.

What is Joe E. Kiani's approval rating as Masimo's CEO?

136 employees have rated Masimo Chief Executive Officer Joe E. Kiani on Glassdoor.com. Joe E. Kiani has an approval rating of 90% among the company's employees.

What other stocks do shareholders of Masimo own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Masimo investors own include NVIDIA (NVDA), Netflix (NFLX), Shopify (SHOP), Okta (OKTA), PayPal (PYPL), Alibaba Group (BABA), Mastercard (MA), Trade Desk (TTD), Walt Disney (DIS) and Twilio (TWLO).

Who are Masimo's major shareholders?

Masimo's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (8.61%), Westfield Capital Management Co. LP (1.30%), Sumitomo Mitsui Trust Holdings Inc. (0.74%), Bamco Inc. NY (0.65%), Jackson Square Partners LLC (0.56%) and Raymond James & Associates (0.34%). Insiders that own company stock include Adam Mikkelson, Craig B Reynolds, Joe E Kiani, Micah W Young and Tao Levy.
View institutional ownership trends
.

How do I buy shares of Masimo?

Shares of MASI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:MASI) was last updated on 5/21/2024 by MarketBeat.com Staff

From Our Partners